Audentes Therapeutics, Inc. announced the appointment of Julie Anne Smith to its board of directors. Julie Anne Smith served as President and Chief Executive Officer of Raptor Pharmaceuticals, Inc. from January 2015 until the company's recent acquisition by Horizon Pharma plc. Previously, Ms. Smith served as Raptor's Executive Vice President and Chief Operating Officer after joining the company in September 2012.